Literature DB >> 13454105

[Practical modifications concerning the determination of antibiotics in clinical practice].

Y CHABBERT, H BOULINGRE.   

Abstract

Keywords:  ANTIBIOTICS/determination

Mesh：

Substances：

Year:  1957        PMID： 13454105

Source DB:  PubMed          Journal:  Rev Fr Etud Clin Biol        ISSN： 0370-4793


× No keyword cloud information.
  20 in total

1.  Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.

Authors:  S Pecquet; E Chachaty; C Tancrède; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Meningoencephalitis due to penicillin-resistant Streptococcus pneumoniae.

Authors:  T Vassal; O Piot; Z Mallat; D Lesage; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella.

Authors:  M E Page-Clisson; H Pinto-Alphandary; E Chachaty; P Couvreur; A Andremont
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Effect of oral ofloxacin on fecal bacteria in human volunteers.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

5.  Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity.

Authors:  J Barre; A Mallat; J Rosenbaum; L Deforges; G Houin; D Dhumeaux; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

6.  Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.

Authors:  A Andremont; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

7.  Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli.

Authors:  A Andremont; G Gerbaud; C Tancrède; P Courvalin
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

8.  Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.

Authors:  L Marty; A Flahault; B Suarez; J Caillon; C Hill; A Andremont
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

9.  Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.

Authors:  E Chachaty; C Bourneix; S Renard; M Bonnay; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

10.  Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.

Authors:  R Leclercq; C Carlier; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.